JBJ-02-112-05
JBJ-02-112-05 is an orally bioavailable, allosteric inhibitor that selectively targets mutant EGFR, specifically the L858R/T790M variant, with high potency (IC50 = 15 nM) . It is a valuable research tool for investigating resistance mechanisms in non-small cell lung cancer (NSCLC) in both cellular and animal models.
Product Specifications
CAS Number
2748162-29-8
Field of Research
Cardiovascular Research, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Smiles
C (C (NC1=NC=CS1) =O) (N2C (=O) C=3C (C2) =CC=C (C3) C=4C=C5C (=CC4) NC=C5) C6=CC=CC=C6
Molecular Formula
C27H20N4O2S
Molecular Weight
464.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NTRK2-4467H 50 µg
Recombinant Human NTRK2 Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details 
M05865-2-Biotin 100 µg/Vial
Anti-GM130 GOLGA2 Antibody Picoband® (monoclonal, 6D4) (Biotine Conjugate)
Sign In for Pricing
View Details FAB10723J 0.1 mL
Mouse Monoclonal TMPRSS2 Antibody (1038127) [Janelia Fluor 646]
Sign In for Pricing
View Details 
LV666178 1.0 µg DNA
CTCF Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details